Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Outlook Therapeutics (OTLK) Return on Equity (2016 - 2025)

Historic Return on Equity for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to 2.64%.

  • Outlook Therapeutics' Return on Equity rose 17500.0% to 2.64% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.64%, marking a year-over-year increase of 17500.0%. This contributed to the annual value of 1.66% for FY2019, which is 6400.0% up from last year.
  • Latest data reveals that Outlook Therapeutics reported Return on Equity of 2.64% as of Q4 2025, which was up 17500.0% from 2.3% recorded in Q3 2025.
  • Outlook Therapeutics' 5-year Return on Equity high stood at 2.64% for Q4 2025, and its period low was 0.89% during Q4 2024.